D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients

Completed

• Conditions: Critical Illness; Pneumonia, Viral

• Registration Number: NCT05279469
• Lead Sponsor: Ain Shams University

Brief Summary

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.

Detailed Description

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.

It has been reported that COVID 19 is associated with hemostatic abnormalities and elevated D-Dimer level, so its level is used to predict severity of disease.

Study Timeline

• Study Start: 2021-06-10
• Status Verified: 2022-03
• Primary Completion: 2022-03-03
• Study Completion: 2022-03-09
• Study First Submitted: 2022-03-10
• Study First Submitted QC: 2022-03-12
• Last Update Submitted: 2022-03-12
• Study First Posted: 2022-03-15
• Last Update Posted: 2022-03-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 465

Inclusion Criteria

• patients of both sex admitted in icu
• positive PCR
• requiring oxygen therapy

Exclusion Criteria

• ward patients
• negative PCR

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
28 days mortality	1 month	Outcomes of ICU stay

Secondary Outcome Measures

Name	Time	Method
length of stay and mechanical ventilation	during ICU stay	time of admission and need to escalate oxygen therapy

Trial Locations

Locations (2)

Ain shams university hospitals; 🇪🇬 Cairo, Egypt

Faculty of medicine, Ain Shams University; 🇪🇬 Cairo, Egypt